bioAffinity Technologies Inc (BIAF)

Name: bioAffinity Technologies Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Diagnostics Research

Latest reporting period: 2025-03-31

Latest Quarter

2025-03-31

Revenue

$1.9M

Net Income

-$2.7M

Operating Margin

-141.7%

Free Cash Flow

-$9.4M

Debt / Assets

33.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for bioAffinity Technologies Inc (BIAF).
Income Statement (Quarterly)	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Revenue	1,854,000	2,208,000	2,350,000	2,398,000
Cost of Revenue	1,368,000	1,562,000	1,440,000	1,408,000
Gross Profit	485,737	645,427	910,228	989,942
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	2,453,000	2,920,000	2,365,000	2,473,000
Operating Expenses	3,113,000	3,592,000	2,884,000	3,078,000
Operating Income	-2,627,000	-2,947,000	-1,974,000	-2,088,000
Interest Expense	15,485	25,045	21,631	22,249
Income Before Tax	-2,652,000	-2,967,000	-1,998,000	-2,105,000
Income Tax Expense	8,695	-23,300	2,559	5,419
Net Income	-2,660,000	-2,967,000	-2,001,000	-2,110,000
Per Share
EPS	-0.16	-0.16	-0.16	-0.19
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for bioAffinity Technologies Inc (BIAF).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	6,161,959	9,362,000	2,532,000	4,803	0
Cost of Revenue	4,731,635	5,983,000	1,741,000	467	0
Gross Profit	1,430,324	3,379,000	791,615	4,336	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	9,913,729	9,943,000	6,791,000	2,727,071	880,772
Operating Expenses	12,002,832	12,332,000	8,765,000	4,015,394	2,206,822
Operating Income	-10,572,508	-8,953,000	-7,973,000	-4,011,058	-2,206,822
Interest Expense	44,372	92,475	37,125	2,532,640	1,001,854
Income Before Tax	-14,865,712	-9,028,350	-7,916,000	-8,151,654	-6,324,463
Income Tax Expense	44,042	11,650	20,993	2,459	1,950
Net Income	-14,909,754	-9,040,000	-7,937,000	-8,154,113	-6,326,413
Per Share
EPS	-8.66	-22.50	-0.91	-1.81	-2.32
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for bioAffinity Technologies Inc (BIAF).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	6,449,782	1,105,291	2,821,570	11,413,759
Short Term Investments	0	0	0	0
Net Receivables	541,962	1,139,204	811,674	10,489
Inventory	53,548	27,608	18,484	5,540
Total Current Assets	7,565,208	2,695,098	3,972,745	11,961,687
Property Plant Equipment	1,261,457	1,619,268	1,994,789	214,438
Goodwill and Intangibles	2,121,292	2,179,625	2,237,958	0
Total Assets	10,960,772	6,513,667	8,221,552	12,182,125
Liabilities
Account Payables	761,901	987,311	604,789	345,042
Short Term Debt	383,871	694,468	460,171	251,746
Total Current Liabilities	2,906,166	3,104,905	2,247,829	1,138,682
Long Term Debt	776,950	806,726	1,118,468	0
Total Liabilities	3,683,116	3,911,631	3,366,297	1,138,682
Shareholders Equity
Retained Earnings	-68,554,064	-53,644,310	-44,604,479	-36,667,468
Total Shareholders Equity	7,277,656	2,602,036	4,855,255	11,043,443

Balance sheet annual history for bioAffinity Technologies Inc (BIAF).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	6,449,782	1,105,291	2,821,570	11,413,759	1,360,638
Short Term Investments	0	0	0	0	0
Net Receivables	541,962	1,139,204	811,674	10,489	1,530
Inventory	53,548	27,608	18,484	5,540	0
Total Current Assets	7,565,208	2,695,098	3,972,745	11,961,687	1,438,233
Property Plant Equipment	1,261,457	1,619,268	1,994,789	214,438	4,633
Goodwill and Intangibles	2,121,292	2,179,625	2,237,958	0	0
Total Assets	10,960,772	6,513,667	8,221,552	12,182,125	1,453,308
Liabilities
Account Payables	761,901	987,311	604,789	345,042	230,407
Short Term Debt	383,871	694,468	460,171	251,746	11,204,225
Total Current Liabilities	2,906,166	3,104,905	2,247,829	1,138,682	13,039,525
Long Term Debt	776,950	806,726	1,118,468	0	160,184
Total Liabilities	3,683,116	3,911,631	3,366,297	1,138,682	17,244,027
Shareholders Equity
Retained Earnings	-68,554,064	-53,644,310	-44,604,479	-36,667,468	-28,513,355
Total Shareholders Equity	7,277,656	2,602,036	4,855,255	11,043,443	-15,790,719

Cash flow quarterly history for bioAffinity Technologies Inc (BIAF).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-14,909,754	-9,039,831	-7,937,011	-8,154,113
Depreciation & Amortization	504,835	605,637	249,592	10,182
Stock Based Compensation	0	989,681	748,823	248,592
Change in Working Capital	594,324	179,718	900,790	114,203
Operating Cash Flow	-9,328,842	-7,264,795	-6,037,806	-4,070,845
Investing Activities
Capital Expenditure	-60,568	-79,083	-22,902	-219,987
Investments	-60,568	-79,083	-22,902	-219,987
Investing Cash Flow	-60,568	-79,083	-2,209,399	-219,987
Financing Activities
Debt Repayment	-369,721	-169,332	-344,984	-694,983
Common Stock Issued/Repurchased	15,103,622	4,350,885	0	6,027,229
Dividends Paid	0	0	0	-185
Financing Cash Flow	14,733,901	5,627,599	-344,984	14,343,953
Summary
Free Cash Flow	-9,389,410	-7,343,878	-6,060,708	-4,290,832
Net Change in Cash	5,344,491	-1,716,279	-8,592,189	10,053,121

Cash flow annual history for bioAffinity Technologies Inc (BIAF).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-14,909,754	-9,039,831	-7,937,011	-8,154,113	-6,326,413
Depreciation & Amortization	504,835	605,637	249,592	10,182	4,817
Stock Based Compensation	0	989,681	748,823	248,592	43,012
Change in Working Capital	594,324	179,718	900,790	114,203	632,821
Operating Cash Flow	-9,328,842	-7,264,795	-6,037,806	-4,070,845	-2,048,978
Investing Activities
Capital Expenditure	-60,568	-79,083	-22,902	-219,987	0
Investments	-60,568	-79,083	-22,902	-219,987	0
Investing Cash Flow	-60,568	-79,083	-2,209,399	-219,987	0
Financing Activities
Debt Repayment	-369,721	-169,332	-344,984	-694,983	0
Common Stock Issued/Repurchased	15,103,622	4,350,885	0	6,027,229	0
Dividends Paid	0	0	0	-185	0
Financing Cash Flow	14,733,901	5,627,599	-344,984	14,343,953	3,326,508
Summary
Free Cash Flow	-9,389,410	-7,343,878	-6,060,708	-4,290,832	-2,048,978
Net Change in Cash	5,344,491	-1,716,279	-8,592,189	10,053,121	1,277,530